Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Statements Author contributions CB: Conceptualization, Investigation, Methodology, Writing original draft
As the potential uses of these drugs expand, such as with recent approvals to prevent heart attacks and strokes in adults with cardiovascular disease who are overweight, the high cost and increased demand for these drugs may increase health spending
These 3 studies blunted the argument to universally intensify glycemic control in all patients: rather, they highlighted the need for individualized glycemic targets
A 2 mL vial at 10 mg/mL concentration provides 4 doses of 5 mg, which is one month of treatment
It is the first approved glucagon-like peptide-1 (GLP-1) receptor agonist that offers automatic dosages adjusted according to the person's individual needs
We're physician-owned, physician-led, and we don't rush these decisions
